Behavioral despair associated with a mouse model of Crohn's disease: Role of nitric oxide pathway
Crohn's disease (CD) is associated with increased psychiatric co-morbidities. Nitric oxide (NO) is implicated in inflammation and tissue injury in CD, and it may also play a central role in pathogenesis of the accompanying behavioral despair. This study investigated the role of the NO pathway i...
Gespeichert in:
Veröffentlicht in: | Progress in neuro-psychopharmacology & biological psychiatry 2016-01, Vol.64, p.131-141 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 141 |
---|---|
container_issue | |
container_start_page | 131 |
container_title | Progress in neuro-psychopharmacology & biological psychiatry |
container_volume | 64 |
creator | Heydarpour, Pouria Rahimian, Reza Fakhfouri, Gohar Khoshkish, Shayan Fakhraei, Nahid Salehi-Sadaghiani, Mohammad Wang, Hongxing Abbasi, Ata Dehpour, Ahmad Reza Ghia, Jean-Eric |
description | Crohn's disease (CD) is associated with increased psychiatric co-morbidities. Nitric oxide (NO) is implicated in inflammation and tissue injury in CD, and it may also play a central role in pathogenesis of the accompanying behavioral despair. This study investigated the role of the NO pathway in behavioral despair associated with a mouse model of CD. Colitis was induced by intrarectal (i.r.) injection of 2,4,6-trinitrobenzenesulfonic acid (10mg TNBS in 50% ethanol). Forced swimming test (FST), pharmacological studies and tissues collection were performed 72h following TNBS administration. To address a possible inflammatory origin for the behavioral despair following colitis induction, tumor necrosis factor-alpha (TNF-α) level was measured in both the hippocampal and colonic tissue samples. In parallel, hippocampal inducible nitric oxide synthase (iNOS) and nitrite level were evaluated. Pharmacological studies targeting the NO pathway were performed 30–60min before behavioral test. Colitis was confirmed by increased colonic TNF-α level and microscopic score. Colitic mice demonstrated a significantly higher immobility time in the FST associated to a significant increase of hippocampal TNF-α, iNOS expression and nitrite content. Acute NOS inhibition using either Nω-nitro-l-arginine methyl ester (a non-specific NOS inhibitor) or aminoguanidine hydrochloride (a specific iNOS inhibitor) decreased the immobility time in colitic groups. Moreover, acute treatment with both NOS inhibitors decreased the TNF-α level and nitrite content in the hippocampal samples. This study suggests that the NO pathway may be involved in the behavioral effects in the mouse TNBS model of CD. These findings endow new insights into the gut-brain communication during the development of colonic inflammation, which may ultimately lead to improved therapeutic strategies to combat behavior changes associated with gastrointestinal disorders.
[Display omitted]
•Colitis in mice is accompanied by an increase in the severity of behavioral despair.•Hippocampal iNOS, TNF-alpha and nitrite level are up-regulated.•NOS & iNOS inhibitors attenuated the behavioral despair and central markers studied. |
doi_str_mv | 10.1016/j.pnpbp.2015.08.004 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1710653006</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0278584615300245</els_id><sourcerecordid>1710653006</sourcerecordid><originalsourceid>FETCH-LOGICAL-c309t-be94c36136e8975bab157d9a7375321224e2e90801e19d8254ae910673de9b683</originalsourceid><addsrcrecordid>eNp9kMFOGzEQQK0KVFLaL6hU-QaXLGN712tX6gGi0iIhIaH2bHntieJos97amwB_j9MARy7jkeaNZ-YR8pVBxYDJi3U1DmM3VhxYU4GqAOoPZMZUq-Y1Z_KIzICXvFG1PCGfcl4DABMgPpITLrlUWvAZsVe4srsQk-2pxzzakKjNObpgJ_T0IUwraukmbjOW6LGncUkXKa6Gs0x9yGgzfqf3scd9YQhTCo7Gx-CRjnZaPdinz-R4afuMX17eU_L3-uefxe_57d2vm8Xl7dwJ0NO8Q107IZmQqHTbdLZjTeu1bUXbCM44r5GjBgUMmfaKN7VFzUC2wqPupBKn5Pzw75jivy3myWxCdtj3dsCyvmFtoRsBIAsqDqhLMeeESzOmsLHpyTAwe7dmbf67NXu3BpQpbkvXt5cB226D_q3nVWYBfhwALGfuAiaTXcDBoQ8J3WR8DO8OeAZjBIq9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1710653006</pqid></control><display><type>article</type><title>Behavioral despair associated with a mouse model of Crohn's disease: Role of nitric oxide pathway</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Heydarpour, Pouria ; Rahimian, Reza ; Fakhfouri, Gohar ; Khoshkish, Shayan ; Fakhraei, Nahid ; Salehi-Sadaghiani, Mohammad ; Wang, Hongxing ; Abbasi, Ata ; Dehpour, Ahmad Reza ; Ghia, Jean-Eric</creator><creatorcontrib>Heydarpour, Pouria ; Rahimian, Reza ; Fakhfouri, Gohar ; Khoshkish, Shayan ; Fakhraei, Nahid ; Salehi-Sadaghiani, Mohammad ; Wang, Hongxing ; Abbasi, Ata ; Dehpour, Ahmad Reza ; Ghia, Jean-Eric</creatorcontrib><description>Crohn's disease (CD) is associated with increased psychiatric co-morbidities. Nitric oxide (NO) is implicated in inflammation and tissue injury in CD, and it may also play a central role in pathogenesis of the accompanying behavioral despair. This study investigated the role of the NO pathway in behavioral despair associated with a mouse model of CD. Colitis was induced by intrarectal (i.r.) injection of 2,4,6-trinitrobenzenesulfonic acid (10mg TNBS in 50% ethanol). Forced swimming test (FST), pharmacological studies and tissues collection were performed 72h following TNBS administration. To address a possible inflammatory origin for the behavioral despair following colitis induction, tumor necrosis factor-alpha (TNF-α) level was measured in both the hippocampal and colonic tissue samples. In parallel, hippocampal inducible nitric oxide synthase (iNOS) and nitrite level were evaluated. Pharmacological studies targeting the NO pathway were performed 30–60min before behavioral test. Colitis was confirmed by increased colonic TNF-α level and microscopic score. Colitic mice demonstrated a significantly higher immobility time in the FST associated to a significant increase of hippocampal TNF-α, iNOS expression and nitrite content. Acute NOS inhibition using either Nω-nitro-l-arginine methyl ester (a non-specific NOS inhibitor) or aminoguanidine hydrochloride (a specific iNOS inhibitor) decreased the immobility time in colitic groups. Moreover, acute treatment with both NOS inhibitors decreased the TNF-α level and nitrite content in the hippocampal samples. This study suggests that the NO pathway may be involved in the behavioral effects in the mouse TNBS model of CD. These findings endow new insights into the gut-brain communication during the development of colonic inflammation, which may ultimately lead to improved therapeutic strategies to combat behavior changes associated with gastrointestinal disorders.
[Display omitted]
•Colitis in mice is accompanied by an increase in the severity of behavioral despair.•Hippocampal iNOS, TNF-alpha and nitrite level are up-regulated.•NOS & iNOS inhibitors attenuated the behavioral despair and central markers studied.</description><identifier>ISSN: 0278-5846</identifier><identifier>EISSN: 1878-4216</identifier><identifier>DOI: 10.1016/j.pnpbp.2015.08.004</identifier><identifier>PMID: 26268932</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>Animals ; Antidepressive Agents - pharmacology ; Behavioral despair ; Colitis - pathology ; Colitis - physiopathology ; Colitis - psychology ; Colon - drug effects ; Colon - metabolism ; Colon - pathology ; Crohn Disease - drug therapy ; Crohn Disease - pathology ; Crohn Disease - physiopathology ; Crohn Disease - psychology ; Depression - drug therapy ; Depression - pathology ; Depression - physiopathology ; Disease Models, Animal ; Enzyme Inhibitors - pharmacology ; Guanidines - pharmacology ; Hippocampus - drug effects ; Hippocampus - metabolism ; Hippocampus - pathology ; Inflammatory bowel disease ; Male ; Mice ; Motor Activity - drug effects ; Motor Activity - physiology ; NG-Nitroarginine Methyl Ester - pharmacology ; Nitric oxide ; Nitric Oxide - metabolism ; Nitric Oxide Synthase Type II - antagonists & inhibitors ; Nitric Oxide Synthase Type II - metabolism ; Nitrites - metabolism ; Signal Transduction - drug effects ; TNF-α ; Trinitrobenzenesulfonic Acid ; Tumor Necrosis Factor-alpha - metabolism</subject><ispartof>Progress in neuro-psychopharmacology & biological psychiatry, 2016-01, Vol.64, p.131-141</ispartof><rights>2015</rights><rights>Copyright © 2015. Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c309t-be94c36136e8975bab157d9a7375321224e2e90801e19d8254ae910673de9b683</cites><orcidid>0000-0002-3018-9719</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.pnpbp.2015.08.004$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26268932$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Heydarpour, Pouria</creatorcontrib><creatorcontrib>Rahimian, Reza</creatorcontrib><creatorcontrib>Fakhfouri, Gohar</creatorcontrib><creatorcontrib>Khoshkish, Shayan</creatorcontrib><creatorcontrib>Fakhraei, Nahid</creatorcontrib><creatorcontrib>Salehi-Sadaghiani, Mohammad</creatorcontrib><creatorcontrib>Wang, Hongxing</creatorcontrib><creatorcontrib>Abbasi, Ata</creatorcontrib><creatorcontrib>Dehpour, Ahmad Reza</creatorcontrib><creatorcontrib>Ghia, Jean-Eric</creatorcontrib><title>Behavioral despair associated with a mouse model of Crohn's disease: Role of nitric oxide pathway</title><title>Progress in neuro-psychopharmacology & biological psychiatry</title><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><description>Crohn's disease (CD) is associated with increased psychiatric co-morbidities. Nitric oxide (NO) is implicated in inflammation and tissue injury in CD, and it may also play a central role in pathogenesis of the accompanying behavioral despair. This study investigated the role of the NO pathway in behavioral despair associated with a mouse model of CD. Colitis was induced by intrarectal (i.r.) injection of 2,4,6-trinitrobenzenesulfonic acid (10mg TNBS in 50% ethanol). Forced swimming test (FST), pharmacological studies and tissues collection were performed 72h following TNBS administration. To address a possible inflammatory origin for the behavioral despair following colitis induction, tumor necrosis factor-alpha (TNF-α) level was measured in both the hippocampal and colonic tissue samples. In parallel, hippocampal inducible nitric oxide synthase (iNOS) and nitrite level were evaluated. Pharmacological studies targeting the NO pathway were performed 30–60min before behavioral test. Colitis was confirmed by increased colonic TNF-α level and microscopic score. Colitic mice demonstrated a significantly higher immobility time in the FST associated to a significant increase of hippocampal TNF-α, iNOS expression and nitrite content. Acute NOS inhibition using either Nω-nitro-l-arginine methyl ester (a non-specific NOS inhibitor) or aminoguanidine hydrochloride (a specific iNOS inhibitor) decreased the immobility time in colitic groups. Moreover, acute treatment with both NOS inhibitors decreased the TNF-α level and nitrite content in the hippocampal samples. This study suggests that the NO pathway may be involved in the behavioral effects in the mouse TNBS model of CD. These findings endow new insights into the gut-brain communication during the development of colonic inflammation, which may ultimately lead to improved therapeutic strategies to combat behavior changes associated with gastrointestinal disorders.
[Display omitted]
•Colitis in mice is accompanied by an increase in the severity of behavioral despair.•Hippocampal iNOS, TNF-alpha and nitrite level are up-regulated.•NOS & iNOS inhibitors attenuated the behavioral despair and central markers studied.</description><subject>Animals</subject><subject>Antidepressive Agents - pharmacology</subject><subject>Behavioral despair</subject><subject>Colitis - pathology</subject><subject>Colitis - physiopathology</subject><subject>Colitis - psychology</subject><subject>Colon - drug effects</subject><subject>Colon - metabolism</subject><subject>Colon - pathology</subject><subject>Crohn Disease - drug therapy</subject><subject>Crohn Disease - pathology</subject><subject>Crohn Disease - physiopathology</subject><subject>Crohn Disease - psychology</subject><subject>Depression - drug therapy</subject><subject>Depression - pathology</subject><subject>Depression - physiopathology</subject><subject>Disease Models, Animal</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Guanidines - pharmacology</subject><subject>Hippocampus - drug effects</subject><subject>Hippocampus - metabolism</subject><subject>Hippocampus - pathology</subject><subject>Inflammatory bowel disease</subject><subject>Male</subject><subject>Mice</subject><subject>Motor Activity - drug effects</subject><subject>Motor Activity - physiology</subject><subject>NG-Nitroarginine Methyl Ester - pharmacology</subject><subject>Nitric oxide</subject><subject>Nitric Oxide - metabolism</subject><subject>Nitric Oxide Synthase Type II - antagonists & inhibitors</subject><subject>Nitric Oxide Synthase Type II - metabolism</subject><subject>Nitrites - metabolism</subject><subject>Signal Transduction - drug effects</subject><subject>TNF-α</subject><subject>Trinitrobenzenesulfonic Acid</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><issn>0278-5846</issn><issn>1878-4216</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMFOGzEQQK0KVFLaL6hU-QaXLGN712tX6gGi0iIhIaH2bHntieJos97amwB_j9MARy7jkeaNZ-YR8pVBxYDJi3U1DmM3VhxYU4GqAOoPZMZUq-Y1Z_KIzICXvFG1PCGfcl4DABMgPpITLrlUWvAZsVe4srsQk-2pxzzakKjNObpgJ_T0IUwraukmbjOW6LGncUkXKa6Gs0x9yGgzfqf3scd9YQhTCo7Gx-CRjnZaPdinz-R4afuMX17eU_L3-uefxe_57d2vm8Xl7dwJ0NO8Q107IZmQqHTbdLZjTeu1bUXbCM44r5GjBgUMmfaKN7VFzUC2wqPupBKn5Pzw75jivy3myWxCdtj3dsCyvmFtoRsBIAsqDqhLMeeESzOmsLHpyTAwe7dmbf67NXu3BpQpbkvXt5cB226D_q3nVWYBfhwALGfuAiaTXcDBoQ8J3WR8DO8OeAZjBIq9</recordid><startdate>20160104</startdate><enddate>20160104</enddate><creator>Heydarpour, Pouria</creator><creator>Rahimian, Reza</creator><creator>Fakhfouri, Gohar</creator><creator>Khoshkish, Shayan</creator><creator>Fakhraei, Nahid</creator><creator>Salehi-Sadaghiani, Mohammad</creator><creator>Wang, Hongxing</creator><creator>Abbasi, Ata</creator><creator>Dehpour, Ahmad Reza</creator><creator>Ghia, Jean-Eric</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3018-9719</orcidid></search><sort><creationdate>20160104</creationdate><title>Behavioral despair associated with a mouse model of Crohn's disease: Role of nitric oxide pathway</title><author>Heydarpour, Pouria ; Rahimian, Reza ; Fakhfouri, Gohar ; Khoshkish, Shayan ; Fakhraei, Nahid ; Salehi-Sadaghiani, Mohammad ; Wang, Hongxing ; Abbasi, Ata ; Dehpour, Ahmad Reza ; Ghia, Jean-Eric</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c309t-be94c36136e8975bab157d9a7375321224e2e90801e19d8254ae910673de9b683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Antidepressive Agents - pharmacology</topic><topic>Behavioral despair</topic><topic>Colitis - pathology</topic><topic>Colitis - physiopathology</topic><topic>Colitis - psychology</topic><topic>Colon - drug effects</topic><topic>Colon - metabolism</topic><topic>Colon - pathology</topic><topic>Crohn Disease - drug therapy</topic><topic>Crohn Disease - pathology</topic><topic>Crohn Disease - physiopathology</topic><topic>Crohn Disease - psychology</topic><topic>Depression - drug therapy</topic><topic>Depression - pathology</topic><topic>Depression - physiopathology</topic><topic>Disease Models, Animal</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Guanidines - pharmacology</topic><topic>Hippocampus - drug effects</topic><topic>Hippocampus - metabolism</topic><topic>Hippocampus - pathology</topic><topic>Inflammatory bowel disease</topic><topic>Male</topic><topic>Mice</topic><topic>Motor Activity - drug effects</topic><topic>Motor Activity - physiology</topic><topic>NG-Nitroarginine Methyl Ester - pharmacology</topic><topic>Nitric oxide</topic><topic>Nitric Oxide - metabolism</topic><topic>Nitric Oxide Synthase Type II - antagonists & inhibitors</topic><topic>Nitric Oxide Synthase Type II - metabolism</topic><topic>Nitrites - metabolism</topic><topic>Signal Transduction - drug effects</topic><topic>TNF-α</topic><topic>Trinitrobenzenesulfonic Acid</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Heydarpour, Pouria</creatorcontrib><creatorcontrib>Rahimian, Reza</creatorcontrib><creatorcontrib>Fakhfouri, Gohar</creatorcontrib><creatorcontrib>Khoshkish, Shayan</creatorcontrib><creatorcontrib>Fakhraei, Nahid</creatorcontrib><creatorcontrib>Salehi-Sadaghiani, Mohammad</creatorcontrib><creatorcontrib>Wang, Hongxing</creatorcontrib><creatorcontrib>Abbasi, Ata</creatorcontrib><creatorcontrib>Dehpour, Ahmad Reza</creatorcontrib><creatorcontrib>Ghia, Jean-Eric</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Progress in neuro-psychopharmacology & biological psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Heydarpour, Pouria</au><au>Rahimian, Reza</au><au>Fakhfouri, Gohar</au><au>Khoshkish, Shayan</au><au>Fakhraei, Nahid</au><au>Salehi-Sadaghiani, Mohammad</au><au>Wang, Hongxing</au><au>Abbasi, Ata</au><au>Dehpour, Ahmad Reza</au><au>Ghia, Jean-Eric</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Behavioral despair associated with a mouse model of Crohn's disease: Role of nitric oxide pathway</atitle><jtitle>Progress in neuro-psychopharmacology & biological psychiatry</jtitle><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><date>2016-01-04</date><risdate>2016</risdate><volume>64</volume><spage>131</spage><epage>141</epage><pages>131-141</pages><issn>0278-5846</issn><eissn>1878-4216</eissn><abstract>Crohn's disease (CD) is associated with increased psychiatric co-morbidities. Nitric oxide (NO) is implicated in inflammation and tissue injury in CD, and it may also play a central role in pathogenesis of the accompanying behavioral despair. This study investigated the role of the NO pathway in behavioral despair associated with a mouse model of CD. Colitis was induced by intrarectal (i.r.) injection of 2,4,6-trinitrobenzenesulfonic acid (10mg TNBS in 50% ethanol). Forced swimming test (FST), pharmacological studies and tissues collection were performed 72h following TNBS administration. To address a possible inflammatory origin for the behavioral despair following colitis induction, tumor necrosis factor-alpha (TNF-α) level was measured in both the hippocampal and colonic tissue samples. In parallel, hippocampal inducible nitric oxide synthase (iNOS) and nitrite level were evaluated. Pharmacological studies targeting the NO pathway were performed 30–60min before behavioral test. Colitis was confirmed by increased colonic TNF-α level and microscopic score. Colitic mice demonstrated a significantly higher immobility time in the FST associated to a significant increase of hippocampal TNF-α, iNOS expression and nitrite content. Acute NOS inhibition using either Nω-nitro-l-arginine methyl ester (a non-specific NOS inhibitor) or aminoguanidine hydrochloride (a specific iNOS inhibitor) decreased the immobility time in colitic groups. Moreover, acute treatment with both NOS inhibitors decreased the TNF-α level and nitrite content in the hippocampal samples. This study suggests that the NO pathway may be involved in the behavioral effects in the mouse TNBS model of CD. These findings endow new insights into the gut-brain communication during the development of colonic inflammation, which may ultimately lead to improved therapeutic strategies to combat behavior changes associated with gastrointestinal disorders.
[Display omitted]
•Colitis in mice is accompanied by an increase in the severity of behavioral despair.•Hippocampal iNOS, TNF-alpha and nitrite level are up-regulated.•NOS & iNOS inhibitors attenuated the behavioral despair and central markers studied.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>26268932</pmid><doi>10.1016/j.pnpbp.2015.08.004</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-3018-9719</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0278-5846 |
ispartof | Progress in neuro-psychopharmacology & biological psychiatry, 2016-01, Vol.64, p.131-141 |
issn | 0278-5846 1878-4216 |
language | eng |
recordid | cdi_proquest_miscellaneous_1710653006 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Animals Antidepressive Agents - pharmacology Behavioral despair Colitis - pathology Colitis - physiopathology Colitis - psychology Colon - drug effects Colon - metabolism Colon - pathology Crohn Disease - drug therapy Crohn Disease - pathology Crohn Disease - physiopathology Crohn Disease - psychology Depression - drug therapy Depression - pathology Depression - physiopathology Disease Models, Animal Enzyme Inhibitors - pharmacology Guanidines - pharmacology Hippocampus - drug effects Hippocampus - metabolism Hippocampus - pathology Inflammatory bowel disease Male Mice Motor Activity - drug effects Motor Activity - physiology NG-Nitroarginine Methyl Ester - pharmacology Nitric oxide Nitric Oxide - metabolism Nitric Oxide Synthase Type II - antagonists & inhibitors Nitric Oxide Synthase Type II - metabolism Nitrites - metabolism Signal Transduction - drug effects TNF-α Trinitrobenzenesulfonic Acid Tumor Necrosis Factor-alpha - metabolism |
title | Behavioral despair associated with a mouse model of Crohn's disease: Role of nitric oxide pathway |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T23%3A36%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Behavioral%20despair%20associated%20with%20a%20mouse%20model%20of%20Crohn's%20disease:%20Role%20of%20nitric%20oxide%20pathway&rft.jtitle=Progress%20in%20neuro-psychopharmacology%20&%20biological%20psychiatry&rft.au=Heydarpour,%20Pouria&rft.date=2016-01-04&rft.volume=64&rft.spage=131&rft.epage=141&rft.pages=131-141&rft.issn=0278-5846&rft.eissn=1878-4216&rft_id=info:doi/10.1016/j.pnpbp.2015.08.004&rft_dat=%3Cproquest_cross%3E1710653006%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1710653006&rft_id=info:pmid/26268932&rft_els_id=S0278584615300245&rfr_iscdi=true |